Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human TNFRSF10D Antikörper:
anti-Mouse (Murine) TNFRSF10D Antikörper:
anti-Rat (Rattus) TNFRSF10D Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal TNFRSF10D Primary Antibody für ELISA, ICC - ABIN4361837
Mitsiades, Poulaki, Tseleni-Balafouta, Koutras, Stamenkovic: Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. in Cancer research 2000
Show all 19 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für CyTOF, ELISA (Capture) - ABIN4900417
Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. in Journal of cellular biochemistry 2008
Show all 14 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN4897669
Stary, Klein, Kohlhofer, Koszik, Scherzer, Müllauer, Quendler, Kohrgruber, Stingl: Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. in Blood 2009
Show all 11 Pubmed References
Human Polyclonal TNFRSF10D Primary Antibody für CyTOF, FACS - ABIN4900418
Zauli, Pandolfi, Gonelli, Di Pietro, Guarnieri, Ciabattoni, Rana, Vitale, Secchiero: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. in Circulation research 2003
Show all 7 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für ICC, FACS - ABIN1169231
Washburn, Weigand, Grosse-Wilde, Janke, Stahl, Rieser, Sprick, Schirrmacher, Walczak: TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus. in Journal of immunology (Baltimore, Md. : 1950) 2003
Show all 3 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN536705
Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006
Show all 3 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN536704
Falschlehner, Emmerich, Gerlach, Walczak: TRAIL signalling: decisions between life and death. in The international journal of biochemistry & cell biology 2007
Show all 3 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN1383933
Baritaki, Katsman, Chatterjee, Yeung, Spandidos, Bonavida: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. in Journal of immunology (Baltimore, Md. : 1950) 2007
Show all 2 Pubmed References
Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN1383934
Vermot-Desroches, Sergent, Bonnin, Wijdenes: Characterization of monoclonal antibodies directed against trail or trail receptors. in Cellular immunology 2005
The high-dose hook effect was apparent during ELISA testing of uDcR2 in chronic kidney disease (CKD) patients, yet dilution of the urine samples neutralized this effect. However, the use of a four-fold dilution of urine for uDcR2/cre testing may eliminate the high-dose hook effect and make it possible to effectively monitor the severity of TII in CKD patients.
results suggest that CD264 is a surface marker of cellular age for bone marrow-derived mesenchymal stem cells.
Urinary DcR2 could potentially serve as a novel biomarker for tubulointerstitial injury and may reflect senescence of renal proximal tubular cells in diabetic nephropathy.
Results identified epigenetic inactivation of TNFRSF10C and TNFRSF10D in majority of cervical cancer cases.
DcRs regulate TRAIL sensitivity at a supracellular level
membrane expression more common in endometrioid endometrial cancer than in normal endometrium
This study identified TNFRSF10D DNA methylation status as an independent prognostic biomarker for relapse-free survival and overall mortality in non-metastatic melanoma patients.
The membrane expression of the TRAIL receptors DR4, DR5, DcR1 and DcR2 is greater in normal endometrium than endometrioid adenocarcinoma (EAC). The level of the receptors in EAC is not dependent on grading and staging and does not predict survival.
the results presented here claim for a relevant impact of aberrant methylation of decoy receptors in melanoma and allow to understand how the silencing of DcR1 and DcR2 is related to melanomagenesis.
transcript levels of UCHL1, COL1A2, THBS1 and TNFRSF10D were inversely correlated with promoter methylation
TRAIL receptor-4 expression profiles on T cells might be important in revelation of rheumatoid arthritis pathogenesis.
ANT2 shRNA treatment sensitized MCF7, T47 D, and BT474 cells to TRAIL-induced apoptosis by up-regulating the expression of TRAIL death receptors 4 and 5 (DR4 and DR5) and down-regulating the TRAIL decoy receptor 2 (DcR2).
these results demonstrated that hypoxia-inducible factor 1alpha played a crucial role in regulating the transcription of DcR2.
TNF-related apoptosis-inducing ligand (TRAIL) is not constitutively expressed in the human brain, whereas both apoptosis-mediating and apoptosis-blocking TRAIL receptors are found on neurons, astrocytes, and oligodendrocytes
Enhanced expression of DcR2 promotes peripheral blood eosinophil survival in the airways of allergic asthmatics following segmental antigen challenge.
Cytotoxicity and apoptosis induced by TRAIL to beta-cell lines CM were inhibited competitively by soluble TRAIL receptors, R1, R2, R3 or R4.
likely to be involved in chronic pancreatitis; pancreatic stellate cells may directly contribute to acinar regression by inducing apoptosis of parenchymal cells in a TRAIL-dependent manner
Respiratory syncytial virus infection strongly up-regulated the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its functional receptors death receptor 4 (DR4) and DR5.
Our results demonstrate that DcR1 and DcR2 genes are frequently methylated in various tumor types and aberrant methylation was the cause for silencing of DcR1 and DcR2 expression.
The DcR2 was found to have a truncated and non-functional death domain.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain, a transmembrane domain, and a truncated cytoplamic death domain. This receptor does not induce apoptosis, and has been shown to play an inhibitory role in TRAIL-induced cell apoptosis.
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
, TNF receptor-related receptor for TRAIL
, TNF-related apoptosis-inducing ligand receptor 4
, TRAIL receptor 4
, TRAIL receptor with a truncated death domain
, decoy receptor 2
, tumor necrosis factor receptor superfamily member 10D